GAIA
Company Overview
GAIA is focused on developing evidence-based, safe, and accessible digital therapeutics that support patients in restoring and maintaining their mental and physical health.
With over 20 years of expertise, GAIA has developed more than 70 products and demonstrated clinically proven effectiveness in over 19 randomized controlled trials (RCTs) and 2 meta-analyses.
Mission and Expertise
Their mission is to provide digital therapeutics with the same effect size, safety profile, and convenience as pharmaceutical solutions, catering to physicians, therapists, payers, and patients.
The GAIA team comprises multidisciplinary experts including physicians, psychotherapists, clinical scientists, IT and software engineers, regulatory affairs specialists, and market access professionals.
Their flagship product, deprexis®, is an online program for treating depression, proven effective in numerous RCTs and real-life clinical settings, matching the efficacy of antidepressants.